ID: ALA5286952

Max Phase: Preclinical

Molecular Formula: C15H14N2O3

Molecular Weight: 270.29

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1cc2c([nH]c3ccccc32)c([C@H](C)O)n1

Standard InChI:  InChI=1S/C15H14N2O3/c1-8(18)13-14-10(7-12(17-13)15(19)20-2)9-5-3-4-6-11(9)16-14/h3-8,16,18H,1-2H3/t8-/m0/s1

Standard InChI Key:  NEDDJLBVOBPXID-QMMMGPOBSA-N

Associated Targets(Human)

NCI-H187 598 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.29Molecular Weight (Monoisotopic): 270.1004AlogP: 2.56#Rotatable Bonds: 2
Polar Surface Area: 75.21Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.61CX Basic pKa: 1.68CX LogP: 1.95CX LogD: 1.95
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.70Np Likeness Score: 0.45

References

1. Luo B, Song X..  (2021)  A comprehensive overview of β-carbolines and its derivatives as anticancer agents.,  224  [PMID:34332400] [10.1016/j.ejmech.2021.113688]

Source